Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Marc Lajoie
|
| gptkbp:focusesOn |
synthetic biology
immunotherapy gene therapy |
| gptkbp:foundedYear |
2020
|
| gptkbp:founder |
gptkb:David_Baker
gptkb:Casey_Cunningham Marc Lajoie |
| gptkbp:headquartersLocation |
gptkb:Seattle,_Washington,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Outpace Bio
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:mission |
to engineer cell therapies with enhanced function and control
|
| gptkbp:notableInvestment |
gptkb:Khosla_Ventures
gptkb:Northpond_Ventures gptkb:Decheng_Capital gptkb:Lyell_Immunopharma ARTIS Ventures |
| gptkbp:website |
https://outpacebio.com
|
| gptkbp:bfsParent |
gptkb:Artis_Ventures
gptkb:Vijay_S._Pande |
| gptkbp:bfsLayer |
8
|